# Milestone 1 Deliverables - Data Preparation

**Project:** KiHealth Diabetes Prediction (Transfer Learning)  
**Contractor:** Stroom AI, LLC (Parker Case)  
**Completion Date:** January 31, 2026  
**Status:** Complete

---

## Executive Summary

Milestone 1 successfully completed. Created a world-class cross-population dataset of **38,509 samples** from **2 countries** (USA and China) with **35,444 HOMA-eligible samples** and **5,240 diabetes cases** (13.6%) for transfer learning-based diabetes prediction. **33,078** samples are used for model training (HOMA-eligible, valid glucose/insulin). NHANES cycles: 2013-14, 2015-16, 2017-20, 2021-23; C-Pep NHANES 1999-2004; DIQ integration adds self-reported diabetes/prediabetes and treatment data where available.

---

## Key Achievements

✅ **Cross-Population Dataset:** 35,444 HOMA-eligible samples across USA and China; 5,240 diabetes cases (33,078 used for training)  
✅ **Multi-National:** NHANES (USA) + CHNS (China) gold standard data  
✅ **Transfer Learning Ready:** Source domain (USA) + Target domain (China) validation  
✅ **DIQ Integration:** Self-reported diabetes, prediabetes, insulin use, diabetes pills (NHANES)  
✅ **High Quality:** <1% missing data, 99%+ valid HOMA calculations  
✅ **Complete ETL Pipeline:** Automated data loading and processing  
✅ **Comprehensive Documentation:** 15+ documentation files  
✅ **HIPAA Compliant:** Full compliance package included  

---

## Contents

### 1. Documentation (`docs/`)

**Data Documentation:**
- KiHealth_Data_Summary.md - Complete data overview
- M1_Data_Quality_Report.md - Comprehensive quality analysis
- CHNS_Transfer_Learning_Assessment.md - CHNS dataset evaluation
- HOMA_Calculations.md - HOMA-IR/beta formulas and validation
- Project_Setup.md - Environment setup guide
- PHASE1_ASSESSMENT.md - Phase 1 completion assessment

**HIPAA Compliance Package:**
- HIPAA_Deidentification_Protocol.md - Safe Harbor compliance
- Access_Control_Policy.md - Data access and security
- Incident_Response_Plan.md - Breach response procedures
- Data_Retention_Policy.md - Retention and deletion policy

---

### 2. Code (`code/`)

**ETL Pipeline:**
- `src/data/load_kihealth.py` - Unified data loader
  - load_nhanes_cycle() - NHANES data + optional DIQ merge
  - load_chns() - CHNS data
  - load_frankfurt() - Frankfurt/Pima data
  - load_diabd() - DiaBD data
  - build_unified_kihealth() - Combines all sources

**HOMA Calculations:**
- `src/features/homa_calculations.py` - HOMA-IR/beta formulas with validation

**Notebooks:**
- `notebooks/01_KiHealth_Data_Exploration.ipynb` - Complete data analysis

**Scripts:**
- `scripts/merge_chns_2009.py` - CHNS data merger
- `scripts/download_nhanes_diq.py` - Download NHANES DIQ from CDC
- `scripts/validate_chns_addition.py` - Validation tests
- `scripts/validate_homa_eligibility.py` - HOMA eligibility validation

**Tests:**
- `tests/test_homa_calculations.py` - Unit tests (all passing)

---

### 3. Data Access (`data/`)

**Unified Dataset:** unified_kihealth.csv
- 38,509 total samples
- 28 standardized variables (including DIQ)
- 35,444 HOMA-eligible samples; 33,078 used for training; 5,240 diabetes cases
- See: Data_Access_Instructions.md

**Raw Data Sources:**
- NHANES 2013-14, 2015-16, 2017-20, 2021-23 (CDC)
- CHNS 2009 (UNC/NIH)
- Frankfurt/Pima (UCI ML Repository)
- DiaBD (Mendeley)

---

### 4. Presentation

M1 summary presentation with:
- Data sources integrated
- Key statistics
- Transfer learning strategy
- Quality assurance results
- Deliverables checklist

---

## Dataset Statistics

| Metric | Value |
|--------|-------|
| **Total Samples** | 38,509 |
| **HOMA-Eligible** | 35,444 (92.0%) |
| **Used for Training** | 33,078 |
| **Diabetes Cases** | 5,240 (13.6%) |
| **Countries** | 2 (USA, China) |
| **Datasets** | NHANES x4, CHNS, C-Pep NHANES 1999-2004, Frankfurt, DiaBD |
| **Variables** | 28 standardized |
| **Missing Data** | <1% for key variables |
| **Quality** | Gold standard fasting protocols |

---

## Transfer Learning Composition

**Source Domain (Training):** 33,078 samples (HOMA-eligible, valid glucose/insulin)
- NHANES 2013-2014, 2015-2016, 2017-2020, 2021-2023 (USA)
- C-Pep NHANES 1999-2004 (USA, C-peptide)
- Frankfurt/Pima, DiaBD (supplementary)

**Target Domain (Validation/Adaptation):**
- CHNS 2009: 9,549 samples (China, 99.3% HOMA-valid)

**Cross-Population Benefits:**
- Test generalization across ethnicities
- Validate across dietary patterns
- Robust to population differences
- Strong foundation for methylation integration

---

## Quality Assurance

✅ **HOMA calculations validated** against reference formulas  
✅ **All datasets verified** for fasting measurement protocols  
✅ **Missing data documented** and handled appropriately  
✅ **Invalid samples flagged** (invalid_homa_flag)  
✅ **Dataset eligibility tracked** (homa_analysis_eligible)  
✅ **DIQ merge** for self-reported diabetes/treatment (NHANES)  
✅ **Code tested** (pytest passing, 100% critical path coverage)  
✅ **HIPAA compliant** (Safe Harbor method verified)  

---

## Next Steps (Milestone 2)

Model development begins upon M1 acceptance:

1. **Base Model Training** (NHANES source domain)
2. **Cross-Population Validation** (CHNS target domain)
3. **Domain Adaptation** (if needed)
4. **Methylation Integration** (KiHealth proprietary data)
5. **Target:** AUC >0.85 for HOMA-IR/beta prediction

---

## Contact

**Parker Case**  
Founder & Principal Data Scientist  
Stroom AI, LLC  
parker@stroomai.com
